Nefopam is under investigation for the prevention of Cholecystitis and Post Anaesthetic Shivering. Nefopam has been investigated for the prevention of Kidney Transplantation. Its therapeutic use is listed as analgesics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Fenazoxine, Nefopamum, 1H-2, 5-Benzoxazocine, 3, 4, 5 and 6-tetrahydro-5-methyl-1-phenyl-. Its PubChem CID is 4450.
Nefopam
| CAS No | 13669-70-0 |
|---|---|
| Molecular Formula | C17H19NO |
| Molecular Weight | 253.34 g/mol |
| Synonyms | 5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Nefopam is under investigation for the prevention of Cholecystitis and Post Anaesthetic Shivering. Nefopam has been investigated for the prevention of Kidney Transplantation.
The listed CAS number is 13669-70-0.
The listed molecular formula is C17H19NO.
The listed molecular weight is 253.34 g/mol.
5-methyl-1-phenyl-1,3,4,6-tetrahydro-2,5-benzoxazocine.
The source lists Fenazoxine, Nefopamum, 1H-2, 5-Benzoxazocine, 3, 4, 5 and 6-tetrahydro-5-methyl-1-phenyl-.